#USA #Aliso Viejo #egnite #cardiovascular specialists #CardioCare

Egnite Expands its Medical Advisory Board

Egnite, Inc., a cutting-edge healthcare AI company, has taken a significant step in advancing cardiovascular care by expanding its Medical Advisory Board (MAB) to include three distinguished specialists in cardiology and cardiothoracic surgery. This strategic move aims to enhance egnite's ability to help healthcare providers better identify and manage untreated heart disease among patients.

The newly appointed board members are Dr. Vijay Iyer, Chief of Cardiovascular Medicine at the University at Buffalo; Dr. Daniel Logsdon, Cardiothoracic Surgeon at Eisenhower Health; and Dr. Andrew Morse, Director of the Structural Heart and Valvular Disease Center at Ascension Saint Thomas Medical Partners. Their expertise will play a pivotal role in shaping the development and implementation of egnite's CardioCare® platform, which is already trusted by over 75 health systems and 800 healthcare facilities.

The announcement follows closely with the upcoming New York Valves conference, where clinical leaders from across the nation will discuss advancements in the treatment of structural heart disease. The addition of these experts brings valuable clinical insights that will further strengthen egnite's commitment to offering innovative solutions that align with real-world medical practices.

Advancing Real-World Evidence and Patient Care

Egnite's CardioCare platform is designed not just to identify patients with untreated cardiovascular conditions but also to facilitate their connection to appropriate care based on established guidelines. The platform's utilization of data from nearly 14 million de-identified patient records allows egnite to generate valuable insights and support outcomes research. This data-driven approach empowers clinicians to make informed decisions that can improve overall patient care.

As cardiovascular care becomes increasingly reliant on analytics and evidence, leading organizations will be those that are able to integrate clinical insight with operational efficiency. Joel Portice, the CEO of egnite Health, emphasized that the new appointments enhance the clinical guidance steering egnite's ongoing development and product roadmap, ensuring that their solutions are grounded in practical usage.

Profiles of the New Board Members

Dr. Vijay Iyer

Dr. Iyer is renowned for his extensive background in structural heart interventions, having led the Complex Valve Clinic and the structural heart programs at the Gates Vascular Institute and Buffalo General Medical Center. His practice encompasses a wide range of interventional procedures and he actively engages in research focused on TAVR outcomes and cardiac care innovations. Dr. Iyer noted, “Egnite's platform provides visibility into a patient population that no other tool offers, facilitating better workflow and planning decisions in cardiovascular care.”

Dr. Daniel Logsdon

As a cardiothoracic surgeon with a reputation for excellence, Dr. Logsdon has excelled in performing complex surgeries within a high-acuity community cardiac program. His experiences at Eisenhower Health, where he has achieved remarkable returns on investment with CardioCare, underscore the program’s shift towards proactive rather than reactive care. He highlighted how recognizing and addressing cardiovascular problems early can transform patient outcomes significantly.

Dr. Andrew Morse

Dr. Morse leads a prominent cardiovascular program at Ascension Saint Thomas Medical Partners in Nashville, where he has spearheaded advancements in transcatheter valve therapies. His extensive research involvement reflects his commitment to improving patient outcomes and pioneering innovative therapeutic approaches. He affirmed, “Real-world evidence is crucial to understanding how therapies perform across diverse patient populations, and egnite's registry helps bridge that gap.”

Conclusion

The expansion of egnite’s Medical Advisory Board represents a significant leap towards empowering healthcare providers with the tools they need to address cardiovascular diseases effectively. With the insights from these top specialists, egnite continues to pave the way for innovative practices in heart disease prevention and management. As the company evolves, its focus remains steadfast on enhancing patient care through advanced technological integration, solidifying its role as a leader in cardiovascular intelligence.